Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
MAXCYTE, INC. shareholders approved Approval of the Amended 2022 Plan at the 2023-06-22 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-22
Exact text from the filing
Proposal No. 2: Approval of the Amended 2022 Plan. The votes were cast as follows: Votes For Votes Against Abstained Approval of an amendment and restatement of the 2022 Equity Incentive Plan 67,398,179 9,101,146 217,247 Broker Non-Votes: 6,512,902
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
MAXCYTE, INC. shareholders approved Ratification of the appointment of CohnReznick LLP as independent registered public accounting firm at the 2023-06-22 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-22
Exact text from the filing
Proposal No. 3: Ratification of the appointment of CohnReznick LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of CohnReznick LLP 83,086,872 5,981 136,621
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
MAXCYTE, INC. shareholders approved Election of three nominees to serve as directors until the 2026 annual meeting at the 2023-06-22 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-22
Exact text from the filing
Proposal No. 1: Election of three nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Art Mandell 43,059,349 33,657,223 Stanley C. Erck 45,186,194 31,530,378 Patrick J. Balthrop 76,115,643 600,929 Broker Non-Votes: 6,512,902 All nominees were elected.
View on SEC.gov